GIGLIO, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 751
EU - Europa 265
AS - Asia 83
SA - Sud America 6
AF - Africa 2
OC - Oceania 1
Totale 1.108
Nazione #
US - Stati Uniti d'America 749
IT - Italia 116
SE - Svezia 52
IN - India 35
SG - Singapore 29
IE - Irlanda 23
CN - Cina 17
UA - Ucraina 14
FI - Finlandia 13
GB - Regno Unito 12
DE - Germania 8
FR - Francia 7
AR - Argentina 6
BE - Belgio 6
RO - Romania 5
BG - Bulgaria 3
CA - Canada 2
NL - Olanda 2
PT - Portogallo 2
TG - Togo 2
CH - Svizzera 1
IL - Israele 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 1.108
Città #
Fairfield 135
Chandler 92
Ann Arbor 63
Rome 56
Ashburn 52
Houston 49
Seattle 46
Woodbridge 44
Cambridge 42
Wilmington 32
Dublin 23
San Paolo di Civitate 22
Princeton 20
Lawrence 17
Singapore 15
Beijing 14
Plano 13
Millbury 12
New York 10
San Diego 9
Boston 7
Brussels 6
Helsinki 6
Boardman 5
Bremen 5
Parma 5
Federal 4
Jacksonville 4
Norwalk 4
Anzio 3
Benevento 3
Dearborn 3
Frosinone 3
Lyon 3
Milan 3
Sofia 3
Andover 2
Fremont 2
Lisbon 2
Lomé 2
London 2
Pune 2
Redmond 2
Rieti 2
San Mateo 2
Toronto 2
Anaheim 1
Ariccia 1
Atlanta 1
Auburn Hills 1
Auckland 1
Aurora 1
Avigliano 1
Bern 1
Bratislava 1
Bühl 1
Centro 1
Chengdu 1
Des Moines 1
Fasano 1
Fuzhou 1
Group 1
Istanbul 1
Las Vegas 1
Los Angeles 1
Naples 1
San Jose 1
Shrewsbury 1
Southwark 1
Tappahannock 1
Tel Aviv 1
Xian 1
Totale 879
Nome #
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients 97
MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis 88
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties 87
Autophagy deactivation is associated with severe prostatic inflammation in patients with lower urinary tract symptoms and benign prostatic hyperplasia 72
Identification of an aberrantly spliced form of HDMX in human tumors. a new mechanism for HDM2 stabilization 70
Fhit loss in lung preneoplasia: Relation to DNA damage response checkpoint activation 68
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 68
MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway 65
A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients 64
MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a 63
MicroRNA-551b expression profile in low and high-grade cervical intraepithelial neoplasia 63
Sex-disaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients 61
Usfulness of T2 stir sequences in the evaluation of breast disease 56
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington’s Disease: A Pilot Study 56
Impairment of autophagy may represent the molecular mechanism behind the relationship between obesity and inflammation in patients with BPH and LUTS 52
Serum ferritin is an independent risk factor for acute respiratory distress syndrome in COVID-19 44
miRNAs as candidate biomarker for the accurate detection of atypical endometrial hyperplasia/endometrial intraepithelial neoplasia 40
c-Met and miRs in cancer 38
Papillary Carcinoma of the Thyroid: High Expression of COX-2 and Low Expression of KAI-1/CD82 Are Associated with Increased Tumor Invasiveness 24
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington's disease: A Pilot Study 11
Totale 1.187
Categoria #
all - tutte 3.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 25 9 4 8 20 21 24 29 25 21 21 6
2020/2021126 6 12 5 10 16 5 2 6 26 10 19 9
2021/2022244 8 8 21 10 32 2 5 23 15 14 54 52
2022/2023296 38 66 20 32 32 29 10 23 36 2 7 1
2023/2024108 9 16 3 6 9 26 2 5 3 9 10 10
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 1.187